Skip to content

A study for the releaasing Jingjin node with the blade needle in the treatment of upper extremity spasticity after stroke

A study for the releaasing Jingjin node with the blade needle in the treatment of upper extremity spasticity after stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018501
Enrollment
Unknown
Registered
2018-09-21
Start date
2018-10-15
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper extremity spasticity after stroke

Interventions

therapy group:Blade needle release + routine rehabilitation training
Control group:Reinforcement node acupuncture+routine rehabilitation training

Sponsors

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria for stroke and have an onset between 1 month and 1 year; 2. Patients aged between 30 and 80 years old; 3. Patients with upper limb spastic hemiplegia, using Brunnstrom staging in stage II-III patients, and using the modified Ashworth score to evaluate upper limb muscle tone at level 2 and above; 4. A patient with normal consciousness and ability to correctly express self-esteem and can cooperate with treatment; 5. Those who voluntarily participate in this study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Limb paralysis is caused by non-cerebrovascular diseases such as spinal cord injury, brain trauma, and brain tumor surgery; 2. Patients with conscious disorders and unstable conditions; 3. Patients with severe primary disease of cardiovascular, hepatic, renal, pulmonary, and hematopoietic systems that are not effectively controlled; 4. The patient is in pregnancy and puerperium; 5. Patients with fainting acupuncture reactions, or skin allergies, or pressure ulcers and infections in the spastic limbs; 6. Recently, patients who have taken central sedative drugs or muscle relaxants.Recently,patients' limbs are treated with botulinum toxin, alcohol, or other nerve or exercise point block; 7. Patients undergoing other clinical studies.

Design outcomes

Primary

MeasureTime frame
MAS;Surface electromyography;

Secondary

MeasureTime frame
Simplify the Fugl-Meyer motor function evaluation scale;Barthel index;China Stroke Scale;

Countries

China

Contacts

Public ContactLi Deihua

Chengdu University of Traditional Chinese Medicine

Si_ff@163.com+86 18980079361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026